Cancer Research

All Items

• 

  Circular RNAs novel actors of Wnt signaling pathway in lung cancer progression

  Mina Alimohammadi, Yasaman Gholinezhad, Vahide Mousavi, Samaneh Kahkesh, Malihe Rezaee, Alireza Yaghoobi, Alireza Mafi, Mahmood Araghi

  645-669

• Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer

  Keshav Raj Paudel, Bikash Manandhar, Sachin Kumar Singh, Gaurav Gupta, Philip Michael Hansbro, Dinesh Kumar Chellappan, Kamal Dua

  516-519
• 

  Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation

  Ying Kao, Chung-Hsing Chou, Li-Chun Huang, Chia-Kuang Tsai

  482-498
• 

  Molecular alterations of driver genes in non-small cell lung cancer from diagnostics to targeted therapy

  Anna Grodzka, Agnieszka Knopik-Skrocka, Katarzyna Kowalska, Paweł Kurzawa, Monika Krzyżaniak, Katarzyna Stencel, Maciej Bryl

  415-432
• 

  IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines

  Helen Y. Lorenzo-Anota, Alejandra Reyes-Ruiz, Kenny M. Calvillo-Rodríguez, Rodolfo Mendoza-Reveles, Andrea P. Urdaneta-Peinado, Karla M. Alvarez-Valadez, Ana Carolina Martinez-Torres, Cristina Rodríguez-Padilla

  352-366

• Adenocarcinoma - success so far and the way ahead

  Rabab Fatima, Mousmee Sharma, Parteek Prasher, Gaurav Gupta, Sachin Kumar Singh, Monica Gulati, Kamal Dua

  329-333
• 

  Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications

  Mohammad Alwahsh, Joviana Farhat, Shahd Talhouni, Lama Hamadneh, Roland Hergenröder

  146-168
• 

  The bovine dialyzable leukocyte extract, immunepotent CRP, synergically enhances cyclophosphamide-induced breast cancer cell death, through a caspase-independent mechanism

  Ana Luisa Rivera-Lazarín, Ana Carolina Martinez-Torres, Rafael de la Hoz-Camacho, Olga Liliana Guzmán-Aguillón, Moisés Armides Franco-Molina, Cristina Rodríguez-Padilla

  131-145
• 

  Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells

  Slavomir Krajnak, Jannis Patrik Trier, Pauline Friederike Heinzmann, Katharina Anic, Anne-Sophie Heimes, Amelie Loewe, Marcus Schmidt, Marco Johannes Battista, Annette Hasenburg, Walburgis Brenner

  114-130

• A temporal cluster of acute promyelocytic leukemia

  Stephen E. Langabeer

  67-69
• 

  PARP1pred: a web server for screening the bioactivity of inhibitors against DNA repair enzyme PARP-1

  Tassanee Lerksuthirat, Sermsiri Chitphuk, Wasana Stitchantrakul, Donniphat Dejsuphong, Aijaz Ahmad Malik, Chanin Nantasenamat

  84-107
• 

  Antineoplastic multi-drug chemotherapy to sensitize tumors triggers multi-drug resistance and inhibits efficiency of maintenance treatment in glioblastoma cells

  Oguzhan Doganlar, Zeynep Banu Doğanlar, Suat Erdogan, Emre Delen

  35-52

• The interplay between non-coding RNAs and Wnt/β-catenin signaling pathway in urinary tract cancers from tumorigenesis to metastasis

  Farzad Rahmani, Pegah Safavi, Ayda Fathollahpour, Fatemeh Tanhaye Kalate Sabz, Parastoo Tajzadeh, Mohsen Arefnezhad, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan

  1273-1284

• Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1)

  Akshansh Sharma, Rajiv Tonk, Ravi Shekhar, Sushil Dohare, Deepak Kumar

  904-905

• Integrated bioinformatics analysis reveals that EZH2-rich domains promote transcriptional repression in cervical cancer

  Eric Genaro Salmerón-Bárcenas, Ana Elvira Zacapala-Gómez, Julio Ortiz-Ortiz, Francisco Israel Torres-Rojas, Pedro Antonio Avila-Lopez

  852-868

• Introducing a new index for selecting genetic polymorphisms for association studies

  Nafiseh Omidpanah, Mostafa Saadat

  814-817

• Cytotoxic capability and the associated proteomic profile of cell-free coelomic fluid extracts from the edible sea cucumber Holothuria tubulosa on HepG2 liver cancer cells

  Claudio Luparello, Rossella Branni, Giulia Abruscato, Valentina Lazzara, Laszlo Drahos, Vincenzo Arizza, Manuela Mauro, Vita Di Stefano, Mirella Vazzana

  722-743

• Current update on anticancer effects of icariin A journey of the last ten years

  Mukta Gupta, Yachana Mishra, Vijay Mishra, Murtaza M. Tambuwala

  680-686

• The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity

  Alexis Neumann-Mufweba, Serah Kimani, Saif Feroz Khan, Kelly Chibale, Sharon Prince

  656-679

• IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells

  Serkan Ismail Göktuna

  436-453

• Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma

  Vafa Meftahpour, Ali Aghebati-Maleki, Ali Fotouhi, Elham Safarzadeh, Leili Aghebati-Maleki

  250-268

• Cyclophosphamide and epirubicin induce high apoptosis in microglia cells while epirubicin provokes DNA damage and microglial activation at sub-lethal concentrations

  Rafael de la Hoz-Camacho, Ana Luisa Rivera-Lazarin, Jose Manuel Vazquez-Guillen, Diana Caballero-Hernandez, Edgar Mendoza-Gamboa, Ana Carolina Martinez-Torres, Cristina Rodriguez-Padilla

  197-212

• Epidemiology and biology of early onset colorectal cancer

  Anand Venugopal, John M. Carethers

  162-182

• Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS)

  Amir R. Afshari, Mohammad Jalili-Nik, Mohammad Soukhtanloo, Ahmad Ghorbani, Hamid R. Sadeghnia, Hamid Mollazadeh, Mostafa Karimi Roshan, Farzad Rahmani, Hamed Sabri, Mohammad Mahdi Vahedi, Seyed Hadi Mousavi

  576-590